ID: ALA3594286

Max Phase: Preclinical

Molecular Formula: C13H16Cl2O3

Molecular Weight: 291.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCC(=O)c1c(O)c(Cl)c(C)c(Cl)c1O

Standard InChI:  InChI=1S/C13H16Cl2O3/c1-3-4-5-6-8(16)9-12(17)10(14)7(2)11(15)13(9)18/h17-18H,3-6H2,1-2H3

Standard InChI Key:  PCVSDQVOWQEFQZ-UHFFFAOYSA-N

Associated Targets(non-human)

Drosophila (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.17Molecular Weight (Monoisotopic): 290.0476AlogP: 4.48#Rotatable Bonds: 5
Polar Surface Area: 57.53Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.15CX Basic pKa: CX LogP: 5.98CX LogD: 5.51
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.62Np Likeness Score: 0.78

References

1. Nguyen VH, Kikuchi H, Kubohara Y, Takahashi K, Katou Y, Oshima Y..  (2015)  Development of novel DIF-1 derivatives that selectively suppress innate immune responses.,  23  (15): [PMID:26122773] [10.1016/j.bmc.2015.06.027]

Source